Table 4 HIV-1 gene mutations and drug resistance in this study.

From: Characterization of transmitted drug resistance among recently infected HIV-1 men who have sex with men in Hebei Province, China

Drug

Number of Resistant Cases

Proportion (%)

Primary and Secondary Resistance Mutations

PIs

4

2.31

 

ATV

2

1.16

M46I, M46MGRV, M46MV, N88NS, Q58QE, L90LM

DRV

0

0.00

FPV

1

0.58

IDV

2

1.16

LPV

1

0.58

NFV

4

2.31

SQV

2

1.16

TPV

1

0.58

 

NRTIs

2

1.16

 

ABC

2

1.16

 

AZT

1

0.58

K65R, D67N, K70E

D4T

2

1.16

DDI

2

1.16

FTC

1

0.58

3TC

1

0.58

TDF

2

1.16

 

NNRTIs

4

2.31

 

DOR

2

1.16

 

EFV

3

1.73

K103N, V106M, V106VA, E138G, V179D, V179E, G190A

ETR

0

0.00

NVP

3

1.73

RPV

2

1.16

 

INSTIs

5

2.89

 

BIC

3

1.73

 

CAB

3

1.73

S153SF, G163R, R263RK

DTG

3

1.73

EVG

5

2.89

RAL

4

2.31

 

Total

13

7.51

 
Back to article page